Surrey Heartlands

Joint Formulary & PAD

Oscillating Positive Expiratory Pressure Device - Mucus clearance

You are here : Home > Formulary Search > Oscillating Positive Expiratory Pressure Device - Mucus clearance

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative
Formulations :
  • Device
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NFD2
Restrictions / Comments :
Important

This device has not been assessed for inclusion on the formulary. Contact your pharmacy team for advice on making an application to APC.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Oscillating Positive Expiratory Pressure Device
Indication :
Mucus clearance
Group Name :
Keywords :
Brand Names Include :
Acapella Choice Blue, Aerobika, Flutter, Lungflute, Pari O-PEP, RC-Cornet, RC- Cornet Plus, Shaker Deluxe, Shaker Deluxe Kids,
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Oscillating Positive Expiratory Pressure Device is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Mucus clearance.

  • No records returned.

Committee Recommendations (1)

07 Feb 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

This drug/device has not yet been assessed for formulary status and is not currently on the APC work-plan.

This drug/device has not yet been evaluated by the Surrey Heartlands ICS Area Prescribing Committee (APC).  As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. It is recommended that clinicians contact their medicines management team for further information and advice before prescribing this drug / device.

The APC will consider recommending prescribing of this treatment upon submission of a formal request with its associated evidence. Clinicians can contact syheartlandsicb.APC@nhs.net  if they wish to make a submission.